Alexandria Real Estate Equities (ARE) experiences numerous investment fluctuations, with firms like
Park Avenue Securities and Financial Management Professionals increasing their stakes, and others like
American International Group and
Las Angeles Capital Management reducing their holdings. ARE's stock has shown resilience against competitors, even when enduring losses, and remains a top dividend stock, making it a consideration for portfolio additions. A notable change for ARE is the break below its 200-day moving average. It secured a
long-term 127382 RSF lease with a top 20 pharmaceutical, and celebrated
30 years at the forefront of a $5 trillion industry. Despite fluctuations, ARE's dividends and public offering of
$400,000,000 of Senior Notes due 2036 remain strong. ARE has also been acknowledged as one of the most trustworthy companies in America by Newsweek. Significant events include a new 10-year lease, expansion of existing tenant leases, and the election of
Sheila McGrath to the Board of Directors. The company continues to have an active presence in the life science real estate market, with a focus on nurturing innovative biotech ecosystems.
Alexandria Real Estate Equities ARE News Analytics from Wed, 27 Sep 2023 07:00:00 GMT to Sun, 30 Jun 2024 09:38:35 GMT -
Rating 7
- Innovation 4
- Information 8
- Rumor -6
